MIDATECH PHARMA
MIDATECH PHARMA

An R&D company focused on delivering innovative oncology and rare disease products to patients

Latest News
Apr 20, 2020

Strategic Review Update including Formal Sale Process Appointment of Noble Capital Markets, Inc.

Mar 31, 2020

Announcement of Strategic Review, Termination of R&D Programme, Update on EU GlioKIDS Grant, Directorate Changes

Jan 8, 2020

Positive Results from MTD201-102 Study Support Subcutaneous Route for Long-Acting Octreotide Product

Dec 5, 2019

Midatech Pharma announces confirmation of a €2.6 million EU Grant for further clinical development of MTX110 for the treatment of Diffuse Intrinsic Pontine Glioma, a rare and fatal form of childhood brain cancer

Midatech Science
  Read More